Reversed amidines and methods of using for treating, preventing, or inhibiting leishmaniasis
US6706754B2 · kind B2 · utility
3Cited by
6References
29Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 5, 2001 |
| Grant date | Mar 16, 2004 |
| Priority date | — |
| Expiry date | Nov 5, 2021 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Methods for treating, preventing or inhibiting leishmaniasis in a subject comprising administering to the subject a therapeutically effective amount of at least one compound having the structural formula wherein Y is a heteroatom; R1 and R2 are independently H or an alkyl, cycloalkyl, heterocycloalkyl, aryl, amino or heteroaryl group; and X1, X2, and X3 are independently H or an alkyl, alkoxy, halo, amino, alkylamino, dialkylamino, acylamino, alkylthio, sulfonyl, cyano, carboxy, alkoxycarbonyl, or carbamoyl group are disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.